参考文献

［1］SUNG H, FERLAY J, SIEGEL RL, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71 (3): 209-249.

［2］VACCARELLA S, LAVERSANNE M, FERLAY J, et al. Cervical cancer in Africa, Latin America and the Caribbean and Asia: Regional inequalities and changing trends. Int J Cancer, 2017, 141 (10): 1997-2001.

［3］SHRESTHA AD, NEUPANE D, VEDSTED P, et al. Cervical Cancer Prevalence, Incidence and Mortality in Low and Middle Income Countries: A Systematic Review. APJCP,2018, 19 (2): 319-324.

［4］SIEGEL RL, MILLER KD, JEMAL A. Cancer statistics, 2020. CA Cancer J Clin, 2020, 70 (1): 7-30.

［5］GOMEZ SL, NOONE AM, LICHTENSZTAJN DY, et al. Cancer incidence trends among Asian American populations in the United States, 1990-2008. J Natl Cancer Inst, 2013, 105 (15): 1096-1110.

［6］ARBYN M, WEIDERPASS E, BRUNI L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health, 2020, 8 (2): e191-e203.

［7］ANTTILA A, RONCO G, CLIFFORD G, et al. Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer, 2004, 91 (5): 935-941.

［8］OBEL J, SOUARES Y, HOY D, et al. A systematic review of cervical cancer incidence and mortality in the Pacific Region. APJCP, 2014, 15 (21): 9433-9437.

［9］JEMAL A, SIMARD EP, DORELL C, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst, 2013, 105 (3): 175-201.

［10］ANTTILA A, PUKKALA E, SODERMAN B, et al. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer, 1999, 83 (1): 59-65.

［11］ADEFUYE PO, BROUTET NJ, DE SANJOSE S, et al. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa. Vaccine, 2013, 31 Suppl 5: F53-59.

［12］BRISSON M, KIM JJ, CANFELL K, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 lowincome and lower-middle-income countries. Lancet, 2020, 395 (10224): 575-590.

［13］SANDER BB, REBOLJ M, LYNGE E. Trends of cervical cancer in Greenland: a 60-year overview. Acta Oncol, 2014, 53 (4): 452-461.

［14］SASIENI P. Analysis of trends is insufficient to posit the existence of two aetiological types of cervical cancer. BJOG, 2016, 123 (5): 779.

［15］ZHENG R ZS, Zeng H. Cancer incidence and mortality in China, 2016. Journal of the National Cancer Center, 2016, 2 (1): 1-9.

［16］LI X, ZHENG R, LI X, et al. Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014. Chin J Cancer Res, 2017, 29 (6): 477-486.

［17］LI S, HU T, LV W, et al. Changes in prevalence and clinical characteristics of cervical cancer in the People’s Republic of China: a study of 10, 012 cases from a nationwide working group. Oncologist, 2013, 18 (10): 1101-1107.

［18］刘萍. 中国大陆13年宫颈癌临床流行病学大数据评价. 中国实用妇科与产科杂志, 2018, 34 (1): 41-45.

［19］王春芳, 郑莹, 邱永莉, 等. 上海市2002—2005年宫颈癌病理与预后分析. 上海预防医学, 2007, 19 (4): 149-151.

［20］CANFELL K, KIM JJ, BRISSON M, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet, 2020, 395 (10224): 591-603.

［21］RAMIREZ PT, FRUMOVITZ M, PAREJA R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med, 2018, 379 (20): 1895-1904.

［22］MELAMED A, MARGUL DJ, CHEN L, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer. N Engl J Med, 2018, 379 (20): 1905-1914.

［23］中国子宫颈癌临床诊疗大数据研究项目组. 中国子宫颈癌临床诊疗大数据研究项目第一期总结——腹腔镜与开腹手术肿瘤学结局对比. 中国实用妇科与产科杂志, 2020, 36 (1): 80-85.

［24］ALLEMANI C, MATSUDA T, DI CARLO V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet, 2018, 391 (10125): 1023-1075.

［25］ZENG H, CHEN W, ZHENG R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health, 2018, 6 (5): e555-e567.

［26］WALBOOMERS JM, JACOBS MV, MANOS MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999, 189 (1): 12-19.

［27］戎寿德, 陈汶, 吴令英, 等. 山西省襄垣县宫颈癌危险因素分析. 中华预防医学杂志, 2002, 36 (1): 41-43.

［28］赵方辉, 马俊飞, 乔友林, 等. 人乳头状瘤病毒DNA载量与子宫颈病变的关系. 中华流行病学杂志, 2004, 25 (11): 921-924.

［29］International Collaboration of Epidemiological Studies of Cervical C. Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15, 461 women with cervical carcinoma and 29 164 women without cervical carcinoma from 21 epidemiological studies. Cancer Epidemiol Biomarkers Prev, 2009, 18 (4): 1060-1069.

［30］International Collaboration of Epidemiological Studies of Cervical C, Appleby P, Beral V, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13 541 women with carcinoma of the cervix and 23 017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer, 2006, 118 (6): 1481-1495.

［31］SLATTERY ML, ROBISON LM, SCHUMAN KL, et al. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA, 1989, 261 (11): 1593-1598.

［32］International Collaboration of Epidemiological Studies of Cervical C. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16 563 women with cervical carcinoma and 33 542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer, 2006, 119 (5): 1108-1124.

［33］MORENO V, BOSCH FX, MUNOZ N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet, 2002, 359 (9312): 1085-1092.